Figure 2.
Hypothetical options for the first-line treatment of non-small cell lung cancer for patients with programmed death receptor ligand-1 (PD-L1)<50%.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.